Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

16.02
+0.05000.31%
Post-market: 15.96-0.0600-0.37%19:30 EDT
Volume:3.52M
Turnover:55.50M
Market Cap:2.05B
PE:-39.83
High:16.09
Open:15.72
Low:15.41
Close:15.97
52wk High:20.15
52wk Low:7.07
Shares:128.00M
Float Shares:117.00M
Volume Ratio:1.16
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.61
PE(LYR):-19.00

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Opus Genetics (IRD), NeoGenomics (NEO) and Teladoc (TDOC)

TIPRANKS
·
Apr 30

NeoGenomics Earnings Call Highlights NGS-Led Growth

TIPRANKS
·
Apr 30

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), CG Oncology, Inc. (CGON) and Icon (ICLR)

TIPRANKS
·
Apr 29

China Southern Airlines Acquires 102 A320 NEO Series Aircraft

Stock News
·
Apr 29

NeoGenomics price target raised to $14 from $13 at TD Cowen

TIPRANKS
·
Apr 29

NeoGenomics Raised to Outperform From Market Perform by Leerink Partners

Dow Jones
·
Apr 29

Neogenomics Inc : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $25.00 From $12.00

THOMSON REUTERS
·
Apr 29

Leerink Upgrades NeoGenomics to Outperform From Market Perform, Adjusts Price Target to $25 From $12

MT Newswires Live
·
Apr 29

Neogenomics Inc : Benchmark Raises to Buy From Hold

THOMSON REUTERS
·
Apr 29

NeoGenomics upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
Apr 29

Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), NeoGenomics (NEO)

TIPRANKS
·
Apr 29

NeoGenomics reports Q1 adjusted EPS 1c, consensus 0c

TIPRANKS
·
Apr 29

NeoGenomics raises FY26 revenue view to $797M-$803M from $793M-$801M

TIPRANKS
·
Apr 29

GUIDANCE: (NEO) NeoGenomics Expects Full Year 2026 Revenue Range $797 Million - $803 Million, vs. FactSet Est of $796.7 Million

MT Newswires Live
·
Apr 29

Neogenomics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 29

NeoGenomics Q1 net loss narrows 34% to $17 million; revenue rises 11% to $187 million

Reuters
·
Apr 29

NeoGenomics Q1 Adj. EPS $0.01, Inline, Sales $186.672M Beat $184.509M Estimate

Benzinga Earnings
·
Apr 29

BRIEF-NeoGenomics Q1 Revenue USD 187 Million Vs. IBES Estimate USD 184.5 Million

Reuters
·
Apr 29

Neogenomics Outlook FY Revenue USD 797-803 Million

THOMSON REUTERS
·
Apr 29

Neogenomics Q1 Gross Profit USD 81 Million

THOMSON REUTERS
·
Apr 29